sumatriptan succinate · Meridian Medcl · NDA 022377
Alsuma (Autoinjector)
Earliest generic entry, as listed
26 Aug 2027
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 7811254.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 7811254 | product, use U-1083 | 26 Aug 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 24 Oct 2026Enters 12-month window basis: patent · 022377-00126 Aug 2027
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 022377 · 001 · discontinued | solution, subcutaneous | EQ 6MG BASE/0.5ML (EQ 12MG BASE/ML) | 26 Aug 2027 |